Laparoscopic placement of adjustable gastric band in patients with autoimmune disease or chronic steroid use

Paul Del Prado, Pavlos K. Papasavas, Darren S. Tishler, Andrea M. Stone, Janet S. Ng, Sean Orenstein

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Past medical or family history of autoimmune diseases and patient chronic steroid use are label contraindications for laparoscopic placement of adjustable gastric band (LAGB). We reviewed our experience with placement of LAGB in patients with autoimmune disease or chronic steroid use. Methods: This was a retrospective review of our prospective bariatric database. All patients who underwent LAGB and had a diagnosis of autoimmune disease or chronic steroid use with at least 1-year follow-up data were included in the study. Data on demographics, weight loss, and complications were collected. Results: Sixteen patients with autoimmune diseases or chronic steroid use underwent LAGB. Diseases included were lupus (n = 6), sarcoidosis (n = 4), renal transplant (n = 2), rheumatoid arthritis (n = 1), ulcerative colitis (n = 1), Grave's disease (n = 1), and celiac disease (n = 1). No patients developed infectious complications. One patient required port replacement due to malfunction, and one patient underwent a conversion to gastric bypass due to failure of weight loss. The average preoperative body mass index was 46.8 kg/m2 with an average weight of 292.0 lbs. Average excess weight loss was 39.8 % (range, 7.4 to 95.5 %) at a median follow-up of 54 months. Conclusions: Our review indicates that LAGB in patients with autoimmune diseases or chronic steroid use is safe, with no infectious complications and only one explant. Some of these autoimmune conditions may improve following significant weight loss, but larger studies are required to further substantiate these findings.

Original languageEnglish (US)
Pages (from-to)584-587
Number of pages4
JournalObesity Surgery
Volume24
Issue number4
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Autoimmune Diseases
Stomach
Steroids
Weight Loss
Medical History Taking
Bariatrics
Gastric Bypass
Graves Disease
Celiac Disease
Sarcoidosis
Ulcerative Colitis
Rheumatoid Arthritis
Body Mass Index
Demography
Databases
Transplants
Kidney
Weights and Measures

Keywords

  • Autoimmune disease
  • Laparoscopic adjustable gastric band
  • Steroid

ASJC Scopus subject areas

  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics
  • Medicine(all)

Cite this

Laparoscopic placement of adjustable gastric band in patients with autoimmune disease or chronic steroid use. / Del Prado, Paul; Papasavas, Pavlos K.; Tishler, Darren S.; Stone, Andrea M.; Ng, Janet S.; Orenstein, Sean.

In: Obesity Surgery, Vol. 24, No. 4, 2014, p. 584-587.

Research output: Contribution to journalArticle

Del Prado, Paul ; Papasavas, Pavlos K. ; Tishler, Darren S. ; Stone, Andrea M. ; Ng, Janet S. ; Orenstein, Sean. / Laparoscopic placement of adjustable gastric band in patients with autoimmune disease or chronic steroid use. In: Obesity Surgery. 2014 ; Vol. 24, No. 4. pp. 584-587.
@article{4323940c3e414451ac168a9a5fa35b3f,
title = "Laparoscopic placement of adjustable gastric band in patients with autoimmune disease or chronic steroid use",
abstract = "Background: Past medical or family history of autoimmune diseases and patient chronic steroid use are label contraindications for laparoscopic placement of adjustable gastric band (LAGB). We reviewed our experience with placement of LAGB in patients with autoimmune disease or chronic steroid use. Methods: This was a retrospective review of our prospective bariatric database. All patients who underwent LAGB and had a diagnosis of autoimmune disease or chronic steroid use with at least 1-year follow-up data were included in the study. Data on demographics, weight loss, and complications were collected. Results: Sixteen patients with autoimmune diseases or chronic steroid use underwent LAGB. Diseases included were lupus (n = 6), sarcoidosis (n = 4), renal transplant (n = 2), rheumatoid arthritis (n = 1), ulcerative colitis (n = 1), Grave's disease (n = 1), and celiac disease (n = 1). No patients developed infectious complications. One patient required port replacement due to malfunction, and one patient underwent a conversion to gastric bypass due to failure of weight loss. The average preoperative body mass index was 46.8 kg/m2 with an average weight of 292.0 lbs. Average excess weight loss was 39.8 {\%} (range, 7.4 to 95.5 {\%}) at a median follow-up of 54 months. Conclusions: Our review indicates that LAGB in patients with autoimmune diseases or chronic steroid use is safe, with no infectious complications and only one explant. Some of these autoimmune conditions may improve following significant weight loss, but larger studies are required to further substantiate these findings.",
keywords = "Autoimmune disease, Laparoscopic adjustable gastric band, Steroid",
author = "{Del Prado}, Paul and Papasavas, {Pavlos K.} and Tishler, {Darren S.} and Stone, {Andrea M.} and Ng, {Janet S.} and Sean Orenstein",
year = "2014",
doi = "10.1007/s11695-013-1122-9",
language = "English (US)",
volume = "24",
pages = "584--587",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Laparoscopic placement of adjustable gastric band in patients with autoimmune disease or chronic steroid use

AU - Del Prado, Paul

AU - Papasavas, Pavlos K.

AU - Tishler, Darren S.

AU - Stone, Andrea M.

AU - Ng, Janet S.

AU - Orenstein, Sean

PY - 2014

Y1 - 2014

N2 - Background: Past medical or family history of autoimmune diseases and patient chronic steroid use are label contraindications for laparoscopic placement of adjustable gastric band (LAGB). We reviewed our experience with placement of LAGB in patients with autoimmune disease or chronic steroid use. Methods: This was a retrospective review of our prospective bariatric database. All patients who underwent LAGB and had a diagnosis of autoimmune disease or chronic steroid use with at least 1-year follow-up data were included in the study. Data on demographics, weight loss, and complications were collected. Results: Sixteen patients with autoimmune diseases or chronic steroid use underwent LAGB. Diseases included were lupus (n = 6), sarcoidosis (n = 4), renal transplant (n = 2), rheumatoid arthritis (n = 1), ulcerative colitis (n = 1), Grave's disease (n = 1), and celiac disease (n = 1). No patients developed infectious complications. One patient required port replacement due to malfunction, and one patient underwent a conversion to gastric bypass due to failure of weight loss. The average preoperative body mass index was 46.8 kg/m2 with an average weight of 292.0 lbs. Average excess weight loss was 39.8 % (range, 7.4 to 95.5 %) at a median follow-up of 54 months. Conclusions: Our review indicates that LAGB in patients with autoimmune diseases or chronic steroid use is safe, with no infectious complications and only one explant. Some of these autoimmune conditions may improve following significant weight loss, but larger studies are required to further substantiate these findings.

AB - Background: Past medical or family history of autoimmune diseases and patient chronic steroid use are label contraindications for laparoscopic placement of adjustable gastric band (LAGB). We reviewed our experience with placement of LAGB in patients with autoimmune disease or chronic steroid use. Methods: This was a retrospective review of our prospective bariatric database. All patients who underwent LAGB and had a diagnosis of autoimmune disease or chronic steroid use with at least 1-year follow-up data were included in the study. Data on demographics, weight loss, and complications were collected. Results: Sixteen patients with autoimmune diseases or chronic steroid use underwent LAGB. Diseases included were lupus (n = 6), sarcoidosis (n = 4), renal transplant (n = 2), rheumatoid arthritis (n = 1), ulcerative colitis (n = 1), Grave's disease (n = 1), and celiac disease (n = 1). No patients developed infectious complications. One patient required port replacement due to malfunction, and one patient underwent a conversion to gastric bypass due to failure of weight loss. The average preoperative body mass index was 46.8 kg/m2 with an average weight of 292.0 lbs. Average excess weight loss was 39.8 % (range, 7.4 to 95.5 %) at a median follow-up of 54 months. Conclusions: Our review indicates that LAGB in patients with autoimmune diseases or chronic steroid use is safe, with no infectious complications and only one explant. Some of these autoimmune conditions may improve following significant weight loss, but larger studies are required to further substantiate these findings.

KW - Autoimmune disease

KW - Laparoscopic adjustable gastric band

KW - Steroid

UR - http://www.scopus.com/inward/record.url?scp=84898034256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898034256&partnerID=8YFLogxK

U2 - 10.1007/s11695-013-1122-9

DO - 10.1007/s11695-013-1122-9

M3 - Article

C2 - 24272886

AN - SCOPUS:84898034256

VL - 24

SP - 584

EP - 587

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 4

ER -